Catalyst Wire Dossier Catalyst Wire Dossier

CD5789 (Trifarotene) 50µg/g Cream

trifarotene · Galderma
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CD5789 (Trifarotene) 50µg/g Cream, covering 2019-08-22 to 2019-09-03. Get the full timeline:

Most recent: Clinical Trial Update: Double-Blind Efficacy and Safety of CD5789 (Trifarotene) 50µg/g Cream Versus Vehicle Cream in Acne Vulgaris [Phase 3]

See pricing